Skip to main content

An Overview of Cancer Care in Societies in Transition: Global Perspectives—UAE Experience

  • Chapter
Book cover Cancer Care in Countries and Societies in Transition

Abstract

Cancer is not a modern disease but has clearly existed for many centuries. It is however a more common phenomenon nowadays than previously due to the increase of the world’s population and the relatively advanced age to which people now live, since it is a disease that is more common in elderly ages than in younger ages (World Cancer Report 2008).

The burden of cancer worldwide is continuously rising largely because of the age and growth of the world population alongside an increasing adoption of cancer-causing behaviors, particularly smoking, physical inactivity, and “westernized” lifestyle in economically developing countries. Based on the GLOBOCAN 2008 estimates, about 12.7 million cancer cases and 7.6 million cancer deaths are estimated to have occurred in 2008; of these, 56 % of the cases and 64 % of the deaths occurred in the economically developing world. Cancer is the leading cause of death in economically developed countries and the second leading cause of death in developing countries (CA Cancer J Clin 61:69–90. CV2011 American Cancer Society, Inc., 2011). Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death among females, accounting for 23 % of the total cancer cases and 14 % of the cancer deaths. Lung cancer is the leading cancer site in males, comprising 17 % of the total new cancer cases and 23 % of the total cancer deaths. Breast cancer is now also the leading cause of cancer death among females in economically developing countries, a shift from the previous decade during which the most common cause of cancer death was cervical cancer. Further, the mortality burden for lung cancer among females in developing countries is as high as the burden for cervical cancer, with each accounting for 11 % of the total female cancer deaths. Although overall cancer incidence rates in the developing world are half those seen in the developed world in both sexes, the overall cancer mortality rates are generally similar. Cancer survival tends to be poorer in developing countries, most likely because of a combination of a late stage at diagnosis and limited access to timely and standard treatment. A substantial proportion of the worldwide burden of cancer could be prevented through the application of existing cancer control knowledge and by implementing programs for tobacco control, vaccination (for liver and cervical cancers), and early detection and treatment, as well as public health campaigns promoting physical activity and a healthier dietary intake. Clinicians, public health professionals, and policy makers can play an active role in accelerating the application of such interventions globally (CA Cancer J Clin 61:69–90. CV2011 American Cancer Society, Inc., 2011) (Fig. 19.1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. World Cancer Report 2008.

    Google Scholar 

  2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. Article first published online: 4 Feb 2011; doi:10.3322/caac.20107.

    Article  PubMed  Google Scholar 

  3. Blair I, Sharif AA. Population structure and the burden of disease in the United Arab Emirates. J Epidemiol Global Health. 2012;2:61–71.

    Article  Google Scholar 

  4. Loney T, Cooling RF, Aw TC. Lost in translation? Challenges and opportunities for raising health and safety awareness among a multinational workforce in the United Arab Emirates. Saf Health Work. 2012;3:298–304. doi:10.5491/SHAW.2012.3.4.298.

    Article  PubMed Central  PubMed  Google Scholar 

  5. United Arab Emirates National Bureau of Statistics. United Arab Emirates: United Arab Emirates National Bureau of Statistics; 2011. National population by emirate and sex (2010 mid-year estimates). http://www.uaestatistics.gov.ae/ReportDetailsEnglish/tabid/121/Default.aspx?ItemId=1914&PTID=104&MenuId=1 [cited 15 November 2012].

  6. Statistical Yearbook of Abu Dhabi. United Arab Emirates: Abu Dhabi Statistics Centre. 2011. http://www.scad.ae/en/Pages/StatisticalYearBook.aspx. [cited 15 November 2012].

  7. International Agency of Research on Cancer, GLOBOCAN. Incidence and mortality date for the United Arab Emirates; 2008.

    Google Scholar 

  8. Statistics Centre Abu Dhabi. Health statistics 2010. http://www.scad.ae/SCAD%20Publications/Health%20English.pdf.

  9. Gulf Centre for Cancer Control and Prevention. Saudi Arabia: Riyadh; Ten-year cancer incidence among national of the GCC states, 1998–2007.

    Google Scholar 

  10. Gavel S. The oncology pipeline: maturing, competitive, and growing. Oncol Business Rev. 2008;9:14–6.

    Google Scholar 

  11. Yabroff R, Lamont E, Mariotto A, et al. Costs of care for elderly cancer patients in the United States. J Natl Cancer Inst. 2008;100:630–41.

    Article  PubMed  Google Scholar 

  12. Oliviera C, Bremner K, Pataky R, et al. Understanding the costs of cancer care before and after diagnosis for the 21 most common cancers in Ontaria: a population-based descriptive study. CMAJ Open. 2013. doi:10.9778/cmajo.20120013.

    Google Scholar 

  13. Warren J, Yabroff R, Meekins A, et al. Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst. 2008;100:888–97.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Mariotto A, Yabroff R, Shao Y, Feuer E, Brown M. Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst. 2011;103:117–28.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Levine M, Ganz PA, Haller D. Economic evaluation in the journal of clinical oncology: past, present, and future. J Clin Oncol. 2007;25:614–6.

    Article  Google Scholar 

  16. HAAD Statistics 2001. http://www.haad.ae/HAAD/LinkClick.aspx?fileticket=JY0sMXQXrOU%3d&tabid=1243. Accessed 10 April 2013.

  17. Meropol NJ, Schrag D, Smith TJ, et al. American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol. 2009;27:3868–74.

    Article  PubMed  Google Scholar 

  18. Campbell J, Ramsey S. The costs of treating breast cancer in the US: a synthesis of published evidence. Pharmacoeconomics. 2009;27:199–209.

    Article  PubMed  Google Scholar 

  19. Mariotto B, Yabroff R, Feuer J, et al. Projecting the number of patients with colorectal carcinoma by phases of care in the US; 2000–2020. Cancer Causes Control. 2006;17:1215–26.

    Article  PubMed  Google Scholar 

  20. Hoffman J, Li E, Doloresco F, et al. Projecting future drug expenditure-2012. Am J Health Syst Pharm. 2012;69:405–21.

    Article  PubMed  Google Scholar 

  21. Patient access to cancer drugs in nine countries in the Middle East; Frida Kasteng; Nils Wilking; Bengt Jonsson.

    Google Scholar 

  22. Altekruse SF, Kosary CL, Krapcho M, et al, eds. Surveillance, Epidemiology, and End Results Cancer Statistics Review, 1975–2007. Bethesda, MD: National Cancer Institute; 2010. http://seer.cancer.gov/csr/1975_2007/, based on November 2009 SEER data submission, posted to the SEER Web site, 2010.

  23. http://gulfnews.com/news/gulf/uae/health/free-cancer-screenings-in-abu-dhabi-1.1237981.

  24. Shaheen R. An overview on breast cancer in Abu Dhabi and United Arab Emirates: barriers & opportunities; 2013.

    Google Scholar 

  25. http://www.haad.ae/simplycheck/tabid/127/Default.aspx.

  26. Silbermann M, Fink RM, Min S-J, Mancuso MP, Brant J, Hajjar R, Al-Alfi N, Baider L, Turker I, ElShamy K, Ghrayeb I, Al-Jadiry M, Khader K, Kav S, Charalambous H, Uslu R, Kebudi R, Barsela G, Kuruku N, Mutafoglu K, Ozalp-Senel G, Oberman A, Kislev L, Khleif M, Keoppi N, Nestoros S, Abdalla RF, Rassouli M, Morag A, Sabar R, Nimri O, Al-Qadire M, Al-Khalaileh M, Tayyem M, Doumit M, Punjwani R, Rasheed O, Fallatah F, Can G, Ahmed J, Strode D. Evaluating palliative in middle eastern care needs countries. J Palliat Med. 2015;18(1):18–25. doi:10.1089/jpm.2014.0194.

    Article  PubMed  Google Scholar 

  27. Palliative care: a peaceful, humane global campaign is needed. Lancet 2014;383:487.

    Google Scholar 

  28. Connor SR, Bermedeo MCS (eds). Global atlas of palliative care at the end-of-life. London: Worldwide Palliative Care Alliance, 2014. http://www.Global-atlas-identifies-unmet-need-for-palliative-care/. Accessed 13 May 2014.

  29. Silbermann M, Epner D, Charalmbous H, et al. Promoting new approaches for cancer care in the Middle East. Ann Oncol. 2013;23:5–10.

    Google Scholar 

  30. International Agency for Research on Cancer: GLOBOCAN 2012: Estimated cancer incidence, mortality, and prevalence worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. Accessed 13 May 2014.

  31. Hligginson IJ. Health care needs assessment: palliative care and terminal care. In: Stevens A, Raftery J, editors. Health care needs assessment. Oxford: Oxford Radcliffe Medical; 1997. p. 1–28.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mohammed Jaloudi M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Jaloudi, M., Kanbar, J., James, D.M., El-Salhat, H. (2016). An Overview of Cancer Care in Societies in Transition: Global Perspectives—UAE Experience. In: Silbermann, M. (eds) Cancer Care in Countries and Societies in Transition. Springer, Cham. https://doi.org/10.1007/978-3-319-22912-6_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-22912-6_19

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-22911-9

  • Online ISBN: 978-3-319-22912-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics